0000875045-23-000024.txt : 20230629 0000875045-23-000024.hdr.sgml : 20230629 20230629162438 ACCESSION NUMBER: 0000875045-23-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20230626 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230629 DATE AS OF CHANGE: 20230629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 231057734 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 8-K 1 biib-20230626.htm 8-K biib-20230626
0000875045false00008750452023-06-262023-06-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 26, 2023

Biogen Inc.
(Exact name of registrant as specified in its charter)
Delaware0-1931133-0112644
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

225 Binney Street, Cambridge, Massachusetts 02142
(Address of principal executive offices; Zip Code)
    
Registrant’s telephone number, including area code: (617) 679-2000
Not Applicable
(Former name or former address, if changed since last report.)
    
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.0005 par valueBIIBThe Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.07     Submission of Matters to a Vote of Security Holders.
On June 26, 2023, Biogen Inc. (the “Company”) held its 2023 Annual Meeting of Stockholders (the “Annual Meeting”). The final voting results for the Annual Meeting are as follows:

1.Stockholders elected seven nominees to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and their successors are duly elected and qualified, with the votes cast as follows:
NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
Caroline Dorsa 91,426,287 27,419,853 278,437 8,719,273 
Maria C. Freire75,764,531 43,230,969 129,077 8,719,273 
William A. Hawkins 73,182,735 45,804,008 137,834 8,719,273 
Jesus B. Mantas 92,085,202 26,910,381 128,994 8,719,273 
Eric K. Rowinsky 68,024,971 50,987,191 112,415 8,719,273 
Stephen A. Sherwin93,133,091 25,889,684 101,802 8,719,273 
Christopher A. Viehbacher 116,996,008 2,026,614 101,955 8,719,273 
2.Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
123,393,6444,311,034139,172—

3.Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
82,640,45436,292,390191,7338,719,273
4.Stockholders approved, on an advisory basis, annually as the frequency of the advisory vote on executive compensation, with the votes cast as follows:
1 Year2 Years3 YearsAbstentions
115,841,79775,4562,254,126953,198
5.Stockholders elected Susan K. Langer to the Board of Directors to serve for a one-year term extending until the 2024 annual meeting of stockholders and her successor is duly elected and qualified, with the votes cast as follows:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
64,037,63846,616,5788,470,3618,719,273

Item 9.01     Financial Statements and Exhibits.
(d)    Exhibits
The exhibits listed below are furnished as part of this Current Report on Form 8-K.
Exhibit No.
Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Biogen Inc.
By: /s/ Wendell Taylor                 
Wendell Taylor
Assistant Secretary

Date: June 29, 2023


 EX-101.SCH 2 biib-20230626.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Statement - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 biib-20230626_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 biib-20230626_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page
Jun. 26, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 26, 2023
Entity Registrant Name Biogen Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-19311
Entity Tax Identification Number 33-0112644
Entity Address, Address Line One 225 Binney Street
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02142
City Area Code 617
Local Phone Number 679-2000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0005 par value
Trading Symbol BIIB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000875045
Amendment Flag false
XML 6 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Page
Jun. 26, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 26, 2023
Entity Registrant Name Biogen Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 0-19311
Entity Tax Identification Number 33-0112644
Entity Address, Address Line One 225 Binney Street
Entity Address, City or Town Cambridge
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02142
City Area Code 617
Local Phone Number 679-2000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0005 par value
Trading Symbol BIIB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000875045
Amendment Flag false
XML 7 biib-20230626_htm.xml IDEA: XBRL DOCUMENT 0000875045 2023-06-26 2023-06-26 0000875045 false 8-K 2023-06-26 Biogen Inc. DE 0-19311 33-0112644 225 Binney Street Cambridge MA 02142 617 679-2000 false false false false Common Stock, $0.0005 par value BIIB NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Statement - Cover Page Sheet http://www.biogenidec.com/role/CoverPage Cover Page Statements 1 false false R2.htm 0000002 - Statement - Cover Page Sheet http://www.biogenidec.com/role/CoverPage_1 Cover Page Statements 2 false false All Reports Book All Reports biib-20230626.htm biib-20230626.xsd biib-20230626_lab.xml biib-20230626_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "biib-20230626.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "biib-20230626.htm" ] }, "labelLink": { "local": [ "biib-20230626_lab.xml" ] }, "presentationLink": { "local": [ "biib-20230626_pre.xml" ] }, "schema": { "local": [ "biib-20230626.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "biib", "nsuri": "http://www.biogenidec.com/20230626", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "biib-20230626.htm", "contextRef": "i8b7db8ee8e0a43b8ab73928b1ac28659_D20230626-20230626", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "statement", "isDefault": "true", "longName": "0000001 - Statement - Cover Page", "menuCat": "Statements", "order": "1", "role": "http://www.biogenidec.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": null }, "R2": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "biib-20230626.htm", "contextRef": "i8b7db8ee8e0a43b8ab73928b1ac28659_D20230626-20230626", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Cover Page", "menuCat": "Statements", "order": "2", "role": "http://www.biogenidec.com/role/CoverPage_1", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.biogenidec.com/role/CoverPage", "http://www.biogenidec.com/role/CoverPage_1" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0000875045-23-000024-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000875045-23-000024-xbrl.zip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